Status:
COMPLETED
Acupuncture on Cardiac and Autonomic Function in Human Heart Failure
Lead Sponsor:
The Cleveland Clinic
Conditions:
Chronic Heart Failure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Acupuncture treatment may improve the cardiac function and the quality of life in heart failure patients. These effects may be related to the inhibition of sympathetic activity and/or increased vagal ...
Detailed Description
The primary aim of this study is to evaluate the effect of acupuncture treatment on cardiac sympathetic/vagal activity in chronic heart failure patients. The investigators would like to investigate th...
Eligibility Criteria
Inclusion
- Age ≥ 21 years
- Congestive Heart Failure (CHF), New York Heart Association (NYHA) class II-III, Left Ventricular Eject Fraction (LVEF) ≤40%
- All patients will have sinus rhythm and compensate with individually optimized standard heart failure medications. Routine medications will be continued during the study period
- Able and willing to give informed consent or comply with study procedures.
Exclusion
- Acupuncture treatment within 3 months before the beginning of the study
- Presents with cutaneous eczema at potential acupoints
- Have a history of major bleeding or increased propensity of excessive bleeding due to platelet dysfunction
- Currently taking anti-coagulants (e.g. warfarin)
Key Trial Info
Start Date :
May 13 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01804816
Start Date
May 13 2013
End Date
December 1 2021
Last Update
November 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195